Lindy Life Sci

Portfolio Specification

Assets

West Pharmaceutical Services Inc (WST)

Thermo Fisher Scientific Inc (TMO)

Policy

Rebalancing Interval	Quarterly
Weights Algorithm	Equal Weights

Benchmark

SPDR S&P 500 ETF Trust (SPY)

Policy Report

Backtest Report

From 2008-04-01 to 2025-07-01 (17y 3m)

Returns (annualized)

Portfolio	14.90%
Benchmark	11.45%

Risk (annualized)

Portfolio	24.94%
Benchmark	20.11%

Sharpe (annualized)

Portfolio	0.63
Benchmark	0.58

Excess Return (annualized)

3.45%

Tracking Error (annualized)

18.26%

Information Ratio

0.19

Statistic	Portfolio	Benchmark
Downside Volatility	25.66%	21.36%
Sortino Ratio	0.62	0.55
Calmar Ratio	0.34	0.23
Ulcer Index	14.19	14.87
Max Drawdown	46.48%	51.49%
VaR (99% Confidence)	$-5,800	$-4,678
VaR (99.9% Confidence)	$-7,704	$-6,214
Beta to Benchmark	0.86	N/A

Value at Risk (VaR) is calculated off a $10,000 portfolio value.

Growth Charts

Historical Weights

Return Distribution

Excess Kurtosis

9.10

Skew

-0.39

Data Table

Factor Coefficients
Factor	Portfolio	Benchmark
Market Factor	0.8200	0.8200
Style Factor	-0.1607	-0.1607
Size Factor	0.1132	0.1132
U.S. Tilt (Non U.S.)	0.4044	0.4044

Adjusted R²

Portfolio	0.48
Benchmark	0.97

Intercept

Portfolio	0.00
Benchmark	0.00

Factor Attribution